BURNABY, B.C. – Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that its collaboration to develop treatments for epilepsy with Neurocrine Biosciences, Inc. (Nasdaq: NBIX) achieved a regulatory… Read More
Mend the Gap researchers are collaborating on an innovative approach to SCI healing and recovery. BC – Researchers at the International Collaboration on Repair Discoveries (ICORD) are part of a… Read More
THOUSAND OAKS, CA & WALTHAM, MA – Amgen (NASDAQ:AMGN) and Arrakis Therapeutics today announced a research collaboration focused on the discovery and development of RNA degrader therapeutics against a range… Read More
Roche’s new cloud-based platform connects patient test results, medical records and third-party applications, allowing professionals to monitor patients’ health, adjust treatment protocols, and make quick data-driven patient care decisions anytime,… Read More
VANCOUVER, BC – Aequus Pharmaceuticals Inc. (TSX-V: AQS,OTCQB: AQSZF)(“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to announce a… Read More
